News - Patents


Current filters:


Popular Filters

226 to 250 of 435 results

European Unitary Patent and Patent Box dominate the London patent summit


With a key meeting on the 40-year old saga of the European Single Unitary Patent scheduled for December…


Mylan in patent settlement with Shionogi over Orapred ODT


US generic drugs major Mylan (Nasdaq: MYL) has entered into a patent settlement with Japan's Shionogi…

CIMA LabsGenericsLegalMylan LaboratoriesNorth AmericaOrapred ODTPatentsRespiratory and PulmonaryShionogi

US FTC submits amicus brief on "no-authorized generic" deals to delay generic competition


The US Federal Trade Commission this week filed an amicus brief in the US District Court for the District…

GenericsLegalNorth AmericaPatentsPharmaceutical

Another negative Indian patent ruling, this time for Pfizer's Sutent


In yet another setback for research-based pharmaceutical companies, last week the Indian patent office…

Asia-PacificCiplaGenericsLegalNatco PharmaOncologyPatentsPfizerPharmaceuticalSutent

FTC seeks US Supreme Court review in AndroGel "pay-for-delay" case


At the request of the US Federal Trade Commission, the Solicitor General of the USA petitioned the country's…

Abbott LaboratoriesAndroGelGenericsLegalMen's HealthNorth AmericaPatentsPharmaceuticalSolvayWatson Pharmaceuticals

USA's GPhA files Amicus Brief in Upsher-Smith vs Louisiana Wholesale Drug Co, et al


The USA's Generic Pharmaceutical Association (GPhA) says that it has filed an Amicus Brief ("friend of…

GenericsLegalNorth AmericaPatents

Will China follow India in compulsory licensing of drugs?


Compulsory licensing is emerging as an additional mechanism by which developing countries can make the…


Australian government proposes "tough new standards" for Innovation Patents


Australia's federal government said in media release this week that it is "considering tough new standards…


Pharma vs the world: Big Pharma caught between investors and public


Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Record number of patent infringement actions filed in 2011, says PwC US


The number of patent infringement actions filed in 2011 reached 4,015 - the highest number ever recorded,…

GeneralLegalNorth AmericaPatentsPharmaceutical

India's IPAB rejects Bayer's "stay petition" regarding Nexavar


Over the weekend, the Intellectual Property Appellate Board (IPAB) of Chennai, India, has dismissed the…

Asia-PacificBayerGenericsLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Strong intellectual property protection welcomed by Canadians


More than three-quarters of Canadian citizens agree the country needs better or the same protection of…

North AmericaPatentsPharmaceutical

Impax Labs and Teva settle Concerta litigation with J&J units


USA-based Impax Laboratories (Nasdaq: IPXL) and the US unit of Israel generics giant Teva Pharmaceutical…

ALZA CorpConcertaGenericsImpax LaboratoriesJanssenJohnson & JohnsonNeurologicalNorth AmericaPatentsTeva Pharmaceutical Industries

US and Indian biotech industry find common ground on key issues


The third annual BIO India conference kicked off yesterday in Mumbai with significant agreement among…

Asia-PacificBiotechnologyNorth AmericaPatentsRegulationResearch

India's patent laws under pressure, say UK researchers


In a special report in the prestigious medical journal The Lancet, researchers from Queen Mary, University…


Validity of certain patent claims covering Santarus' Zegerid capsule and powder upheld


US drugmaker Santarus (Nasdaq: SNTS) saw its shares leap 14.2% to $7.06 in regular trading on September…

GenericsLegalNorth AmericaPar PharmaceuticalPatentsPharmaceuticalSantarusZegerid

Impax Labs settles with Genzyme over Renvela and Renagel generics


USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi's…

GenzymeImpax LaboratoriesPatentsPharmaceuticalRenagelRenvelaSanofi

Bayer attempts to block generic Nexavar in India again slammed by MSF


German drug major Bayer (BAYN: DE) yesterday headed to India's Intellectual Property Appellate Board…


Australian Productivity Commission reviews compulsory licensing in the patents system


The Australian Productivity Commission's review into compulsory licensing in the patents system is now…


PhRMA disputes Indian claims relating to cancer drug shortages


In a recent interview with Times of India, a trade association that represents several major generic…

Asia-PacificGenericsNorth AmericaPatentsPharmaceuticalPolitics

226 to 250 of 435 results

Company Spotlight



Back to top